Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

ANN 101

Drug Profile

ANN 101

Alternative Names: ANN-101

Latest Information Update: 23 Jun 2025

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Anodyne Nanotech
  • Class Obesity therapies
  • Mechanism of Action Glucagon-like peptide-1 receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes
  • Available For Licensing Yes

Highest Development Phases

  • Preclinical Obesity

Most Recent Events

  • 23 Jun 2025 ANN 101 is available for licensing as of 23 Jun 2025. https://www.theheropatch.com/
  • 23 Jun 2025 Anodyne Nanotech has patents pending for microneedles and microneedle patches for transdermal drug delivery and methods of making and using the same in USA, Israel, Europe, South Korea, Japan, Australia, Mexico, Brazil, Canada and worldwide
  • 09 Jun 2025 Preclinical trials in Obesity in USA (Transdermal) before June 2025 (Anodyne Nanotech pipeline, June 2025)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top